Skip to Main Content

Paper Details

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
Clin Pharmacol Ther
189
2018
4-hydroxy N-desmethyl tamoxifen, 4-hydroxytamoxifen, CYP2D6, CYP2D6 genetic polymorphisms, CYP2D6 genotype, Patients, Tamoxifen, early, endoxifen, patients, tamoxifen
Author NameAffiliation
Matthew P GoetzMayo Clinic
Matthias Schwab
Matthias SchwabUniversity Hospital
Matthias SchwabDepartment of Pharmacy and Biochemistry, University of Tuebingen
Michael A ProvinceWashington University School of Medicine
Michelle Whirl-CarrilloStanford University
William F SymmansUniversity of Texas MD Anderson Cancer Center
Howard L McLeodMoffitt Cancer Center
Howard L McLeodMoffitt Cancer Center
Mark J RatainCenter for Personalized Therapeutics, University of Chicago
James N IngleMayo Clinic
Teri E KleinStanford University
  • 1 - 12

Datasets

Release 1.2